Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)
Titel:
Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)
Auteur:
Moehler, Markus Schad, Arno Maderer, Annett Atasoy, Ajlan Mauer, Murielle E. Caballero, Carmela Thomaidis, Thomas John, Jestinah M. Mahachie Lang, Istvan Cutsem, Eric Van Freire, João Lutz, Manfred P. Roth, Arnaud